Relationship of CD4 lymphocyte counts to survival in a cohort of hemophiliacs infected with HIV

Multicenter Hemophilia Cohort Study

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Although CD4 positive lymphocyte counts are important predictors of clinical events in persons infected with human immunodeficiency virus (HIV), little is known about their predictive value for survival. We analyzed CD4 counts obtained regularly since 1983 with regard to survival in a multi-center cohort study of 921 HIV-infected hemophiliacs of whom 177 have died. Dates of seroconversion were determined from stored serum samples. Cumulative mortality and actuarial survival rates were calculated from the first time the mean of two consecutive CD4 counts decreased from levels of >500 to 200-499,100-199,50-99, and <50 cells/μ l. The death rate per 100 patient years of observation was 0.87 (95% CI 0.27,1.47) for those with CD4 counts of >500 cells/μ l and increased progressively to 26.23 (95% CI 21.29, 31.17) for those with CD4 counts of <50/μ l. HIV-related deaths occurred in 50 of 58 who died with CD4 counts of <300/μ l compared to 0 of 6 who died with CD4 counts of >500/μ l. The median CD4 count most proximal to death was 39.5 (range, 1-945). The 10-year actuarial estimate of survival from seroconversion was 77.3 ± 2% for 546 persons who seroconverted at age ≥18 years compared to 90.5 ± 2% for 375 persons who seroconverted at age <18. Survival decreased at each CD4 level to a median of 27 months at CD4 counts of <50/μ l. At each CD4 level, younger patients survived longer than older patients. In this cohort, death was 32 times more frequent with very low CD4 counts (<50 cells/μ l) compared to high CD4 counts (<500 cells/μ l). However, among those with very low CD4 counts, survival was much longer than had previously been described and younger age at seroconversion was a positive prognostic factor at all CD4 levels.

Original languageEnglish (US)
Pages (from-to)1095-1098
Number of pages4
JournalJournal of Acquired Immune Deficiency Syndromes
Volume7
Issue number10
StatePublished - Jan 1 1994

Fingerprint

CD4 Lymphocyte Count
HIV
Survival
CD4-Positive T-Lymphocytes
Cohort Studies
Survival Rate
Mortality
Serum

All Science Journal Classification (ASJC) codes

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

@article{5a4ea58c5f164aeead556ca17e328135,
title = "Relationship of CD4 lymphocyte counts to survival in a cohort of hemophiliacs infected with HIV",
abstract = "Although CD4 positive lymphocyte counts are important predictors of clinical events in persons infected with human immunodeficiency virus (HIV), little is known about their predictive value for survival. We analyzed CD4 counts obtained regularly since 1983 with regard to survival in a multi-center cohort study of 921 HIV-infected hemophiliacs of whom 177 have died. Dates of seroconversion were determined from stored serum samples. Cumulative mortality and actuarial survival rates were calculated from the first time the mean of two consecutive CD4 counts decreased from levels of >500 to 200-499,100-199,50-99, and <50 cells/μ l. The death rate per 100 patient years of observation was 0.87 (95{\%} CI 0.27,1.47) for those with CD4 counts of >500 cells/μ l and increased progressively to 26.23 (95{\%} CI 21.29, 31.17) for those with CD4 counts of <50/μ l. HIV-related deaths occurred in 50 of 58 who died with CD4 counts of <300/μ l compared to 0 of 6 who died with CD4 counts of >500/μ l. The median CD4 count most proximal to death was 39.5 (range, 1-945). The 10-year actuarial estimate of survival from seroconversion was 77.3 ± 2{\%} for 546 persons who seroconverted at age ≥18 years compared to 90.5 ± 2{\%} for 375 persons who seroconverted at age <18. Survival decreased at each CD4 level to a median of 27 months at CD4 counts of <50/μ l. At each CD4 level, younger patients survived longer than older patients. In this cohort, death was 32 times more frequent with very low CD4 counts (<50 cells/μ l) compared to high CD4 counts (<500 cells/μ l). However, among those with very low CD4 counts, survival was much longer than had previously been described and younger age at seroconversion was a positive prognostic factor at all CD4 levels.",
author = "{Multicenter Hemophilia Cohort Study} and Ehmann, {W. Christopher} and Eyster, {M. Elaine} and Wilson, {Susan E.} and Andes, {W. Abe} and Goedert, {James J.}",
year = "1994",
month = "1",
day = "1",
language = "English (US)",
volume = "7",
pages = "1095--1098",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

Relationship of CD4 lymphocyte counts to survival in a cohort of hemophiliacs infected with HIV. / Multicenter Hemophilia Cohort Study.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 7, No. 10, 01.01.1994, p. 1095-1098.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Relationship of CD4 lymphocyte counts to survival in a cohort of hemophiliacs infected with HIV

AU - Multicenter Hemophilia Cohort Study

AU - Ehmann, W. Christopher

AU - Eyster, M. Elaine

AU - Wilson, Susan E.

AU - Andes, W. Abe

AU - Goedert, James J.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Although CD4 positive lymphocyte counts are important predictors of clinical events in persons infected with human immunodeficiency virus (HIV), little is known about their predictive value for survival. We analyzed CD4 counts obtained regularly since 1983 with regard to survival in a multi-center cohort study of 921 HIV-infected hemophiliacs of whom 177 have died. Dates of seroconversion were determined from stored serum samples. Cumulative mortality and actuarial survival rates were calculated from the first time the mean of two consecutive CD4 counts decreased from levels of >500 to 200-499,100-199,50-99, and <50 cells/μ l. The death rate per 100 patient years of observation was 0.87 (95% CI 0.27,1.47) for those with CD4 counts of >500 cells/μ l and increased progressively to 26.23 (95% CI 21.29, 31.17) for those with CD4 counts of <50/μ l. HIV-related deaths occurred in 50 of 58 who died with CD4 counts of <300/μ l compared to 0 of 6 who died with CD4 counts of >500/μ l. The median CD4 count most proximal to death was 39.5 (range, 1-945). The 10-year actuarial estimate of survival from seroconversion was 77.3 ± 2% for 546 persons who seroconverted at age ≥18 years compared to 90.5 ± 2% for 375 persons who seroconverted at age <18. Survival decreased at each CD4 level to a median of 27 months at CD4 counts of <50/μ l. At each CD4 level, younger patients survived longer than older patients. In this cohort, death was 32 times more frequent with very low CD4 counts (<50 cells/μ l) compared to high CD4 counts (<500 cells/μ l). However, among those with very low CD4 counts, survival was much longer than had previously been described and younger age at seroconversion was a positive prognostic factor at all CD4 levels.

AB - Although CD4 positive lymphocyte counts are important predictors of clinical events in persons infected with human immunodeficiency virus (HIV), little is known about their predictive value for survival. We analyzed CD4 counts obtained regularly since 1983 with regard to survival in a multi-center cohort study of 921 HIV-infected hemophiliacs of whom 177 have died. Dates of seroconversion were determined from stored serum samples. Cumulative mortality and actuarial survival rates were calculated from the first time the mean of two consecutive CD4 counts decreased from levels of >500 to 200-499,100-199,50-99, and <50 cells/μ l. The death rate per 100 patient years of observation was 0.87 (95% CI 0.27,1.47) for those with CD4 counts of >500 cells/μ l and increased progressively to 26.23 (95% CI 21.29, 31.17) for those with CD4 counts of <50/μ l. HIV-related deaths occurred in 50 of 58 who died with CD4 counts of <300/μ l compared to 0 of 6 who died with CD4 counts of >500/μ l. The median CD4 count most proximal to death was 39.5 (range, 1-945). The 10-year actuarial estimate of survival from seroconversion was 77.3 ± 2% for 546 persons who seroconverted at age ≥18 years compared to 90.5 ± 2% for 375 persons who seroconverted at age <18. Survival decreased at each CD4 level to a median of 27 months at CD4 counts of <50/μ l. At each CD4 level, younger patients survived longer than older patients. In this cohort, death was 32 times more frequent with very low CD4 counts (<50 cells/μ l) compared to high CD4 counts (<500 cells/μ l). However, among those with very low CD4 counts, survival was much longer than had previously been described and younger age at seroconversion was a positive prognostic factor at all CD4 levels.

UR - http://www.scopus.com/inward/record.url?scp=0028167725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028167725&partnerID=8YFLogxK

M3 - Article

C2 - 7916052

AN - SCOPUS:0028167725

VL - 7

SP - 1095

EP - 1098

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 10

ER -